본문 바로가기
KERD
논문KCI 등재

Implantable Devices for Sustained, Intravesical Drug Delivery

이승호|최영빈
대한배뇨장애요실금학회 (Korean Continence Society)|2016.06|International Neurourology Journal|제20권 제2호|pp. 101-106

2

조회

0

다운로드

1

인용

0

참고문헌

키워드

Drug Delivery SystemUrinary Bladder DiseaseIntravesical Drug DeliverySustained Drug Delivery

초록

In clinical settings, intravesical instillation of a drug bolus is often performed for the treatment of bladder diseases. However, it requires repeated instillations to extend drug efficacy, which may result in poor patient compliance. To alleviate this challenge, implantable devices have been developed for the purpose of sustained, intravesical drug delivery. In this review, we briefly summarize the current trend in the development of intravesical drug-delivery devices. We also introduce the most recently developed devices with strong potential for intravesical drug-delivery applications.

Abstract

In clinical settings, intravesical instillation of a drug bolus is often performed for the treatment of bladder diseases. However, it requires repeated instillations to extend drug efficacy, which may result in poor patient compliance. To alleviate this challenge, implantable devices have been developed for the purpose of sustained, intravesical drug delivery. In this review, we briefly summarize the current trend in the development of intravesical drug-delivery devices. We also introduce the most recently developed devices with strong potential for intravesical drug-delivery applications.

참고문헌 (22)

  1. Macdiarmid SA, "Diagnosis of interstitial cystitis", painful bladder syndrome in patients with overactive bladder symptoms, 2007, pp.9, 9~16
  2. Edmondson SD, "Discovery of vibegron: a potent and selective β3 adrenergic receptor agonist for the treatment of overactive bladder", J Med Chem, 59, pp.609~623 (2016)
  3. Argade S, "Biomarkers for interstitial cystitis", painful bladder syndrome, 2016, pp.12, 87~90
  4. Rovner ES, "Once-daily, extended-release formulations of antimuscarinic agents in the treatment of overactive bladder: a review", Eur Urol, 41, pp.6~14 (2002)
  5. Diokno AC, "Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial", Mayo Clin Proc, 78, pp.687~695 (2003)
  6. Lose G, "Intravesical oxybutynin for treating incontinence resulting from an overactive detrusor", BJU Int, 87, pp.767~773 (2001)
  7. Chuang YC, "Intravesical liposome versus oral pentosan polysulfate for interstitial cystitis", painful bladder syndrome, 2009, pp.182, 1393~1400
  8. Parsons CL, "Successful downregulation of bladder sensory nerves with combination of heparin and alkalinized lidocaine in patients with interstitial cystitis", Urology, 65, pp.45~48 (2005)
  9. Oosterlinck W, "A prospective European Organization for Research and Treatment of Cancer Genitourinary Group randomized trial comparing transurethral resection followed by a single intravesical instillation of epirubicin or water in single stage Ta, T1 papillary carcinoma of the bladder", J Urol, 149, pp.749~752 (1993)
  10. Nickel JC, "Intravesical alkalinized lidocaine (PSD597) offers sustained relief from symptoms of interstitial cystitis and painful bladder syndrome", BJU Int, 103, pp.910~918 (2009)
  11. Lazzeri M, "Intravesical infusion of resiniferatoxin by a temporary in situ drug delivery system to treat interstitial cystitis: a pilot study", Eur Urol, 45, pp.98~102 (2004)
  12. Fraser MO, "The future of bladder control-intravesical drug delivery, a pinch of pepper, and gene therapy", Rev Urol, 4, pp.1~11 (2002)
  13. Herbison P, "Effectiveness of anticholinergic drugs compared with placebo in the treatment of overactive bladder: systematic review", BMJ, 326, pp.841~844 (2003)
  14. Lee H, "An intravesical device for the sustained delivery of lidocaine to the bladder", J Control Release, 149, pp.133~139 (2011)
  15. Nickel JC, "Continuous intravesical lidocaine treatment for interstitial cystitis", bladder pain syndrome: safety and efficacy of a new drug delivery device, 2012, pp.4, 143ra100~
  16. Wan LS, "Effects of the Progestasert on the menstrual pattern, ovarian steroids and endometrium", Contraception, 16, pp.417~434 (1977)
  17. Zhou L, "Use of the New Zealand Intensive Medicines Monitoring Programme to study the levonorgestrel-releasing intrauterine device (Mirena)", Pharmacoepidemiol Drug Saf, 12, pp.371~377 (2003)
  18. Kleiner LW, "Evolution of implantable and insertable drug delivery systems", J Control Release, 181, pp.1~10 (2014)
  19. Wright JC, "An in vivo", in vitro comparison with a leuprolide osmotic implant for the treatment of prostate cancer, 2001, pp.75, 1~10
  20. Herrlich S, "Osmotic micropumps for drug delivery", Adv Drug Deliv Rev, 64, pp.1617~1627 (2012)
  21. Rastogi A, "Evaluation of a perforated drug delivery system in mice for prolonged and constant release of a hydrophilic drug", Drug Deliv Transl Res, 2, pp.106~111 (2012)
  22. 박민, "Polymeric Tube-Shaped Devices with Controlled Geometry for Programmed Drug Delivery", Macromolecular Research, 20(9), pp.960~967 (2012), 한국고분자학회

관련 논문AI추천

Research on Novel Intravesical Drug Delivery Devices문홍상대한배뇨장애요실금학회 · International Neurourology Journal2016 · 제20권 제2호Implantable Bladder Sensors for Long-term Monitoring of Bladder Volume김수진대한배뇨장애요실금학회 · International Neurourology Journal2015 · 제19권 제3호Implantable Bladder Sensors: A Methodological Review구치완, 정연호, 최원석, Mathias Naangmenkpeong Dakurah대한배뇨장애요실금학회 · International Neurourology Journal2015 · 제19권 제3호Wireless Bioelectronics for Bladder Function Monitoring김지혜, 임성진한국센서학회 · 센서학회지2025 · 제34권 제5호Emerging Neural Stimulation Technologies for Bladder Dysfunctions김대정, 남윤기, 윤상진, 이구행, 이지웅, 이형섭대한배뇨장애요실금학회 · International Neurourology Journal2015 · 제19권 제1호Applications of Microfluidic Devices for Urology김경숙, 박헌국, 한세직대한배뇨장애요실금학회 · International Neurourology Journal2017 · 제21권 제1호

이 간행물의 다른 논문 (16건)

Extracellular Matrix Revisited: Roles in Tissue Engineering김유환, 신관우, 고효진, 권일근pp. 23-29Altered Secretory Activity of APE1/Ref-1 D148E Variants Identified in Human Patients With Bladder Cancer임재성, 신주현, 주희경, 전병화, 최성아, 이유란pp. 30-37Neuroprotective Effects of Bone Marrow Stromal Cell Transplantation in Combination With Treadmill Exercise Following Traumatic Brain Injury박헌경, 김태운, 지은상, 이재민, 최한성, 김미예, 김영표, 신말순pp. 49-56Postnatal Treadmill Exercise Alleviates Prenatal Stress-Induced Anxiety in Offspring Rats by Enhancing Cell Proliferation Through 5-Hydroxytryptamine 1A Receptor Activation윤상윤, 김태운, 이삼준, 문은진, 신동훈, 박헌경, 조한진, 유안희pp. 57-64Current Challenges of Geriatric Voiding Dysfunction in South Korea조성태pp. 87-88
원문 보기